Psychiatry beyond the current paradigm

British Journal of Psychiatry

Volumn 201, Issue 6, 2012, Pages 430-434

  Bracken, Pat ^a   Thomas, Philip ^b   Timimi, Sami ^c   Asen, Eia ^d   Behr, Graham ^d   Beuster, Carl ^e   Bhunnoo, Seth ^f   Browne, Ivor ^g   Chhina, Navjyoat ^h   Double, Duncan ⁱ   Downer, Simon ^j   Evans, Chris ^k   Fernando, Suman ^l   Garland, Malcolm R ^m   Hopkins, William ⁿ   Huws, Rhodri ^o   Johnson, Bob ^p   Martindale, Brian ^q   Middleton, Hugh ^r   Moldavsky, Daniel ^k   Moncrieff, Joanna ^s   Mullins, Simon ^t   Nelki, Julia ^u   Pizzo, Matteo ^f   Rodger, James ^v   Smyth, Marcellino ^w   Summerfield, Derek ^x   Wallace, Jeremy ^y   Yeomans, David ^z   more..

^a Republic of Ireland   (Ireland)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

^c LINCOLNSHIRE PARTNERSHIP NHS FOUNDATION TRUST   (United Kingdom)

^d CENTRAL AND NORTH WEST LONDON NHS FOUNDATION TRUST   (United Kingdom)

^e SOUTHERN HEALTH NHS FOUNDATION TRUST   (United Kingdom)

^f ST ANN S HOSPITAL   (United Kingdom)

^g UNIVERSITY COLLEGE DUBLIN   (Ireland)

^h Carleton Clinic   (United Kingdom)

ⁱ NORFOLK AND SUFFOLK NHS FOUNDATION TRUST   (United Kingdom)

^j Severn Deanery   (United Kingdom)

^k NOTTINGHAMSHIRE HEALTHCARE NHS TRUST   (United Kingdom)

^l LONDON METROPOLITAN UNIVERSITY   (United Kingdom)

^m St Ita's Hospital   (Ireland)

ⁿ BARNET ENFIELD AND HARINGEY MENTAL HEALTH NHS TRUST   (United Kingdom)

^o Eastglade Community Health Centre   (United Kingdom)

^p Rivington House Clinic   (United Kingdom)

^q TYNE AND WEAR NHS FOUNDATION TRUST   (United Kingdom)

^r UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^s UNIVERSITY COLLEGE LONDON   (United Kingdom)

^t SHEFFIELD HEALTH AND SOCIAL CARE NHS FOUNDATION TRUST   (United Kingdom)

^u Chester Eating Disorders Service   (United Kingdom)

^v DEVON PARTNERSHIP NHS TRUST   (United Kingdom)

^w Centre for Mental Health Care and Recovery   (Ireland)

^x SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^y HUS (Helsinki University Sairaala) Peijas   (Finland)

^z LEEDS AND YORK PARTNERSHIP NHS FOUNDATION TRUST   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; NEUROLEPTIC AGENT; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

BEHAVIOR; BIOTECHNOLOGY; BRAIN; BRIEF PSYCHIATRIC RATING SCALE; COGNITIVE THERAPY; CONVALESCENCE; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDUSTRY; DSM-IV; ELECTROCONVULSIVE THERAPY; EVIDENCE BASED PRACTICE; HUMAN; LIFE EVENT; LIFE EXPECTANCY; MEDICINE; MENTAL DISEASE; MENTAL HEALTH; MENTAL HEALTH ORGANIZATION; MENTAL HEALTH SERVICE; NEUROSCIENCE; OUTCOME ASSESSMENT; POSITIVE AND NEGATIVE SYNDROME SCALE; PRACTICE GUIDELINE; PSYCHIATRIST; PSYCHIATRY; PSYCHOPHARMACOLOGY; PSYCHOTHERAPY; REVIEW; RISK FACTOR;

BIOMEDICAL TECHNOLOGY; COGNITIVE THERAPY; ELECTROCONVULSIVE THERAPY; EVIDENCE-BASED PRACTICE; HUMANS; KNOWLEDGE; MENTAL DISORDERS; MENTAL HEALTH; PROFESSIONAL PRACTICE; PSYCHIATRY; RECOVERY OF FUNCTION;

EID: 84870344451     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.112.109447     Document Type: Review

References (67)

1. Radden J. Thinking about the repair manual: technique and technology in psychiatry. In Philosophical Perspectives on Technology and Psychiatry (ed J Philips): 263-77. Oxford University Press, 2008.
2. Craddock N, Antebi D, Attenburrow M-J, Bailey A, Carson A, Cowen P, et al. Wake-up call for British psychiatry. Br J Psychiatry 2008; 193: 6-9. (Pubitemid 351946802)
3. Bullmore E, Fletcher P, Jones PB. Why psychiatry can't afford to be neurophobic. Br J Psychiatry 2009; 194: 293-5.
4. Oyebode F, Humphreys M. The future of psychiatry. Br J Psychiatry 2011; 199: 439-40.
5. Insel TR, Quiron R. Psychiatry as a clinical neuroscience discipline. JAMA 2005; 294: 2221-4. (Pubitemid 41571141)
6. Kingdon D, Young AH. Research into putative biological mechanisms of mental disorders has been of no value to clinical psychiatry. Br J Psychiatry 2007; 191: 285-90. (Pubitemid 47555976)
7. Rose S. The need for a critical neuroscience: from neuroideology to neurotechnology. In Critical Neuroscience: A Handbook of the Social and Cultural Contexts of Neuroscience (eds S Choudhury, J Slaby): 53-66. Wiley-Blackwell, 2012.
8. Vul E, Harris C, Winkelmann P, Pashler H. Puzzlingly high correlations in fMRI studies of emotion, personality, and social cognition. Perspect Psychol Sci 2009; 4: 319-24.
9. Angermeyer MC, Holzinger A, Carta MG, Schomerus G. Biogenetic explanations and public acceptance of mental illness: systematic review of population studies. Br J Psychiatry 2011; 199: 367-72.
10. Slade M. Personal Recovery and Mental Illness. Cambridge University Press, 2009.
11. Gronfein W. Psychotropic drugs and the origins of deinstitutionalization. Soc Probl 32: 437-54.
12. Aviram U, Syme Sl, Cohen JB. The effects of policies and programs on reduction of mental hospitalization. Soc Sci Med 1976; 10: 571-7. (Pubitemid 8057230)
13. Porter R. A Social History of Madness: Stories of the Insane. Weidenfeld and Nicolson, 1987.
14. Harré R, Gillett G. The Discursive Mind. Sage, 1994.
15. Ingleby D. Critical Psychiatry: The Politics of Mental Health. Penguin, 1980.
16. Angell M. The illusions of psychiatry. New York Rev Books 2011, July (http://www.nybooks.com/articles/archives/2011/jul/14/illusions-of-psychiatry/? pagination = false).
17. Angell M. The epidemic of mental illness: why? New York Rev Books 2011, 23 June (http://www.nybooks.com/articles/archives/2011/jun/23/epidemicmental- illness-why/).
18. Frances A. The first draft of DSM-V: if accepted, will fan the flames of false positive diagnoses. BMJ 2010; 340: c1168.
19. Carey B, Harris G. Psychiatric group faces scrutiny over drug industry ties. New York Times 2008; 12 July (http://www.nytimes.com/2008/07/12/ washington/12psych.html?pagewanted = all).
20. Andrews G. Placebo response in depression: bane of research, boon to therapy. Br J Psychiatry 2001; 178: 192-4. (Pubitemid 32183598)
21. Kirsch I, Sapirstein G. Listening to prozac but hearing placebo: a metaanalysis of antidepressant medication 1998. Prev Treat 1998; 1: 0002a.
22. National Institute for Health and Clinical Excellence (NICE) (2009). Depression: The Treatment and Management of Depression in Adults. NICE Clinical Guideline CG90. London: NICE (http://guidance.nice.org.uk/CG90).
23. Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA 2010; 303: 47-53.
24. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 2008; 5: e45.
25. Thompson JJ, Ritenbaugh C, Nichter M. Reconsidering the placebo response from a broad anthropological perspective. Cult Med Psychiatry 2009; 33: 112-52.
26. McQueen D, St John Smith P. Placebo effects: a new paradigm and relevance to psychiatry. Int Psychiatry 2012; 9: 1-3.
27. Moerman D. Meaning, Medicine and the 'Placebo Effect'. Cambridge University Press, 2002.
28. Moncrieff J. The Myth of the Chemical Cure: A Critique of Psychiatric Drug Treatment. Palgrave Macmillan, 2008
29. Rasmussen K. Sham electroconvulsive therapy studies in depressive illness: a review of the literature and consideration of the placebo phenomenon in electroconvulsive therapy practice. J ECT 2009; 25: 54-9.
30. Read J, Bentall R. The effectiveness of electroconvulsive therapy: a literature review. Epidemiol Psichiatr Soc 2010; 19: 333-47.
31. Johnstone EC, Deakin JFW, Lawler P, Frith CD, Stevens M, McPherson K. The Northwick Park electroconvulsive therapy trial. Lancet 1980; 2: 1317-20. (Pubitemid 11253165)
32. Kendell R. The present state of electroconvulsive therapy. Br J Psychiatry 1981; 139: 265-83
33. Beck AT. Cognitive therapy: past, present, and future. J Consult Clin Psychol 1993; 61: 194-8. (Pubitemid 23120436)
34. Jacobson NS, Dobson KS, Truax PA, Addis M, Koerner K, Gollan JK, et al. A component analysis of cognitive-behavioural treatment for depression. J Consult Clin Psychol 1996; 64: 295-304.
35. Longmore RJ, Worrell M. Do we need to challenge thoughts in cognitive behaviour therapy? Clin Psychol Rev 2007; 27: 173-87. (Pubitemid 46137943)
36. Budd R, Hughes I. The dodo bird verdict - controversial, inevitable and important: a commentary on 30 years of meta-analyses. Clin Psychol Psychother 2009; 16: 510-22.
37. Cooper M. Essential Research Findings in Counselling and Psychotherapy: The Facts are Friendly. Sage, 2008.
38. Castonguay LG, Beutler LE. Common and unique principles of therapeutic change: what do we know and what do we need to know? In Principles of Therapeutic Change that Work (eds LG Castonguay, LE Beutler): 353-69. Oxford University Press, 2006.
39. Stiles WB, Barkham M, Mellor-Car J. Effectiveness of cognitive- behavioural, person-centred, and psychodynamic therapies in UK primary-care routine practice: replication in a larger sample. Psychol Med 2008; 38: 677-88. (Pubitemid 351483231)
40. National Institute for Health and Clinical Excellence (2009) Quick Reference Guide. Depression: Treatment and Management of Depression in Adults, including Adults with a Chronic Physical Health Problem. London: NICE (http://www.nice.org.uk/nicemedia/live/12329/45890/45890.pdf).
41. Davidson L. Living Outside Mental Illness: Qualitative Studies of Recovery in Schizophrenia. New York University Press, 2003.
42. Frank AF, Gunderson JG. The role of the therapeutic alliance in the treatment of schizophrenia. Arch Gen Psychiatry 1990; 47: 228-36.
43. Harrow M, Jobe TH. Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: a 15-year multifollow-up study. J Nerv Ment Dis 2007; 195: 406-14. (Pubitemid 46763242)
44. Mancini MA, Hardiman ER, Lawson HA. Making sense of it all: consumer providers' theories about factors facilitating and impeding recovery from psychiatric disabilities. Psychiatr Rehabil J 2005; 29: 48-55. (Pubitemid 41022409)
45. Tew J, Ramon S, Slade M, Bird V, Melton J, Le Boutillier C. Social factors and recovery from mental health difficulties: a review of the evidence. Br J Soc Work 2012; 42: 443-60.
46. Leamy M, Bird V, Le Boutillier C, Williams J, Slade M. Conceptual framework for personal recovery in mental health: systematic review and narrative synthesis. Br J Psychiatry 2011; 199: 445-52.
47. Raguram R, Venkateswaran A, Ramakrishna J, Weiss MG. Traditional community resources for mental health: a report of temple healing from India. BMJ 2002; 325: 38-40. (Pubitemid 34747943)
48. Seebohm P, Henderson P, Munn-Giddings C, Thomas P, Yasmeen S. Together We Will Change: Community Development, Mental Health and Diversity. Sainsbury Centre for Mental Health, 2005.
49. Halliburton M. Finding a fit: psychiatric pluralism in South India and its implications for WHO studies of mental disorder. Transcult Psychiatry 2004; 41: 80-98. (Pubitemid 38578439)
50. Warner R. How much of the burden of schizophrenia is alleviated by treatment? Br J Psychiatry 2003; 183: 375-6. (Pubitemid 37357565)
51. Lepping P, Sambhi RS, Whittington R, Lane S, Poole R. Clinical relevance of findings in trials of antipsychotics: systematic review. Br J Psychiatry 2011; 198: 341-5.
52. Bola JR, Kao DT, Soydan H. Antipsychotic medication for early-episode schizophrenia. Schizophr Bull 2012; 38: 23-5.
53. Tyrer P, Kendall T. The spurious advance of antipsychotic drug therapy. Lancet 2009; 373: 4-5.
54. Kendall T. The rise and fall of the atypical antipsychotics. Br J Psychiatry 2011; 199: 266-8.
55. Foley DL, Morley KI. Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis. Arch Gen Psychiatry 2011; 68: 609-16.
56. Thornicroft G. Physical health disparities and mental illness: the scandal of premature mortality. Br J Psychiatry 2011; 199: 441-2.
57. Kirmayer LJ, Gold I. Re-socializing psychiatry: critical neuroscience and the limits of reductionism. In Critical Neuroscience: A Handbook of the Social and Cultural Contexts of Neuroscience (eds S Choudhury, J Slaby): 307-30. Wiley-Blackwell, 2012.
58. Warner R. Does the scientific evidence support the recovery model? Psychiatrist 2010; 34: 3-5.
59. Campbell P. The service user/survivor movement. In Mental Health Still Matters (eds J Reynolds, R Muston, T Heller, J Leach, M McCormick, J Wallcraft and M Walsh): 46-52. Open University/Palgrave Macmillan, 2009.
60. Wallcraft J, Read J, Sweeney A. On Our Own Terms: Users and Survivors of Mental Health Services Working Together for Support and Change. Sainsbury Centre for Mental Health, 2003.
61. MindFreedom. Global Campaign News. MindFreedom, no date (http://www.mindfreedom.org/campaign/global).
62. Romme M, Escher S. Accepting Voices. MIND, 1993.
63. Stastny P, Lehmann P. Alternatives Beyond Psychiatry. Peter Lehmann Publishing, 2007.
64. Rogers A, Pilgrim D, Lacey R. Experiencing Psychiatry: Users' Views of Services. MacMillan, 1993.
65. Roberts G, Wolfson P. The rediscovery of recovery: open to all. Adv Psychiatr Treat 2004; 10: 37-48. (Pubitemid 38072813)
66. Kleinman A, van der Geest S. 'Care' in health care. Remaking the moral world of medicine. Med Anthropol 2009; 21: 159-68.
67. Heath I. Divided we fall. The 2011 Harveian oration delivered to the Royal College of Physicians on October 18th 2011. Clin Med 2011; 11: 576-86.